Ms Elena Nicod

Page Contents >


Elena Nicod is a Research Officer at LSE Health. Her main areas of interest include pharmaceutical pricing, reimbursement and market access. Her research focuses on Health Technology Assessment (HTA) as a resource allocation tool, and aims to identify the criteria driving these recommendations by comparing their decision-making processes across a number of countries in view of possible improvements of HTA methodologies. Other research projects focus on the burden of illness of a retinal disorder, and the costing of a retinal surgical procedure in the UK. She is also participating in a number of EU-projects (Advance-HTA, Burqol, Rare-BP).

Elena is currently undertaking a PhD in Social Policy at the LSE, and  holds an MSc HPPF from the London School of Hygiene and Tropical Medicine, and a BSc/MSc in Business Administration from HEC Lausanne, Switzerland. Prior to LSE, Elena worked as Coordinator of a clinical trial unit at the CHUV Lausanne, and as administrator of the Swiss Vaccine Research Institute during its launch in 2009.

Research interests: Pharmaceutical economics and policy, with a particular focus on Health Technology Assessment (HTA) and its application for rare diseases and orphan drugs.


Jackson TJ, Nicod E, Angelis A, Grimaccia F, Prevost T, Simpson A, Kanavos P (2013). Pars plana viterctomy for vitreomacular syndrome: a systematic review and metaanalysis of safety and efficacy. Retina, 33 (10). pp. 2012-17.

Jackson TJ, Nicod E, Angelis A, Grimaccia F, Prevost T, Simpson A, Kanavos P (2013). Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and meta-analysis. Retina, 33 (6). pp. 1099-1108.

Jackson TJ, Simpson A, Nicod E, Angelis A, Grimaccia F, Kanavos P. (2013) Symptomatic vitreomacular adhesion: a review. Retina, 33 (8). pp. 1503-11.



Nicod E, Kanavos P. 2012. "Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions". Health policy (Amsterdam) (0168-8510) (accepted for publication September 2012, online)

Kanavos P, Nicod E. 2012. "What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward". Value in health (1098-3015) (accepted for publication September 2012, online)

Nicod E, 2010. "Harmonizing the outcomes of HTA: An application to Central Nervous System treatments". EuroObserver. Winter 2010. Volume 12, Number 4.

Kanavos P, Nicod E, Van den Aardweg S, Pomedli S, 2010. "The impact of health technology assessments: An international comparison". EuroObserver. Winter 2010. Volume 12, Number 4.

Kanavos P, Vandoros S, Irwin R, Nicod E, Casson M. 2010. "The European Pharmaceutical market and policies - Outlook for the future". European Parliament. Directorate General for Internal Policies. Policy Department A: economic and scientific Policy.